Víctor Moreno researcher
Moreno Aguado, Víctor
VIAF ID: 87848174 (Personal)
Permalink: http://viaf.org/viaf/87848174
Preferred Forms
-
- 100 1 0 ‡a Moreno Aguado, Víctor
- 100 0 _ ‡a Víctor Moreno ‡c researcher
4xx's: Alternate Name Forms (5)
5xx's: Related Names (1)
Works
Title | Sources |
---|---|
Anàlisi bioinformàtica de la base genética de la susceptibilitat al càncer de mama | |
Anàlisi de dades de seqüenciació de nova generació pel diagnòstic molecular del càncer hereditari i per la recerca de les bases genètiques del càncer colorectal esporàdic | |
Anàlisi molecular del càncer colorectal mitjançant un enfocament computacional integratiu | |
Aplicación de los métodos estadísticos secuenciales al diseño y análisis de estudios de casos y controles | |
Cap a un model complet de la xarxa molecular alterada en l’anèmia de Fanconi i el càncer de mama | |
Caracterización de alteraciones genéticas en el cáncer colorrectal | |
Cervical cancer and pre-cancer in the EPIC cohort: the role of environmental cofactors = El càncer de coll uterí i els seus precursos en la cohort EPIC: el rol dels cofactors ambientals | |
Connexió entre la diversitat de genotips virals i les manifestacions clíniques de la infecció pel virus del Papil·loma | |
Dietary intake and biomarkers of acrylamide exposure and risk of endometrial and ovarian cancer : a molecular epidemiologic study in the European Prospective Investigation into Cancer and Nutrition | |
Factors de risc associats al càncer de cèrvitx : modelització de variables predictores contínues | |
Genetic diversity of human papillomavirus infections in anogenital warts and cancers | |
Integrative approaches for gene and molecular pathway analysis in cancer | |
The link between the centrosome, TSC disease and epithelial differentiation = Estudi de la conexió entre el centrosomo, l'esclorosi tuberosana i la diferenciació epitelial | |
Menstrual and Reproductive Factors and Risk of Gastric and Colorectal Cancer in Spain | |
Meta- and pooled analyses of the methylenetetrahydrofolate reductase | |
Metode bayesià per a l'anàlisi d'haplotips en estudis d'associació genètica : aplicació a dades d'esquizofrènia i càncer | |
Métodos para la determinación de genotipos a partir de datos de microarrays de genotipado | |
miR-1269 promotes metastasis and forms a positive feedback loop with TGF-β. | |
Modulation of Fexofenadine Pharmacokinetics by Osimertinib in Patients With Advanced EGFR-Mutated Non-Small Cell Lung Cancer | |
Molecular epidemiology study on genetically regulated gene expression in the colonic mucosa and its role in disease susceptibility | |
Multiple functional risk variants in a SMAD7 enhancer implicate a colorectal cancer risk haplotype | |
Mutational load distribution analysis yields metrics reflecting genetic instability during pancreatic carcinogenesis | |
Mutations in TP53 are a prognostic factor in colorectal hepatic metastases undergoing surgical resection. | |
NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2-3, randomised, controlled trial | |
Network modeling links breast cancer susceptibility and centrosome dysfunction | |
Next-generation sequencing meets genetic diagnostics: development of a comprehensive workflow for the analysis of BRCA1 and BRCA2 genes | |
Nivolumab Monotherapy and Nivolumab Plus Ipilimumab in Recurrent Small Cell Lung Cancer: Results From the CheckMate 032 Randomized Cohort | |
Novel insights into the molecular mechanisms underlying risk of colorectal cancer from smoking and red/processed meat carcinogens by modeling exposure in normal colon organoids | |
Novel methylation panel for the early detection of colorectal tumors in stool DNA. | |
NTHL1 biallelic mutations seldom cause colorectal cancer, serrated polyposis or a multi-tumor phenotype, in absence of colorectal adenomas. | |
Optimization of RAS/BRAF Mutational Analysis Confirms Improvement in Patient Selection for Clinical Benefit to Anti-EGFR Treatment in Metastatic Colorectal Cancer. | |
OX40 Agonist BMS-986178 Alone or in Combination With Nivolumab and/or Ipilimumab in Patients With Advanced Solid Tumors | |
Pathologic predictors of microsatellite instability in colorectal cancer | |
Perinatal and childhood factors and risk of breast cancer subtypes in adulthood. | |
Pharmacogenomics in colorectal cancer: a genome-wide association study to predict toxicity after 5-fluorouracil or FOLFOX administration | |
Phase 1 study of cetuximab in combination with 5-fluorouracil, cisplatin, and radiotherapy in patients with locally advanced anal canal carcinoma | |
Phase I Study of Lysine-Specific Demethylase-1 Inhibitor CC-90011 in Patients With Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin Lymphoma | |
Physical activity domains and risk of gastric adenocarcinoma in the MCC-Spain case-control study. | |
Polymorphisms affecting micro-RNA regulation and associated with the risk of dietary-related cancers: a review from the literature and new evidence for a functional role of rs17281995 (CD86) and rs1051690 (INSR), previously associated with colorecta | |
Polymorphisms in regulators of xenobiotic transport and metabolism genes PXR and CAR do not affect multiple myeloma risk: a case-control study in the context of the IMMEnSE consortium. | |
Polymorphisms in sulfotransferasesSULT1A1 andSULT1A2 are not related to colorectal cancer | |
Polymorphisms of the dopamine receptor gene DRD2 and colorectal cancer risk | |
Population-based multicase-control study in common tumors in Spain (MCC-Spain): rationale and study design. | |
Possible role of chondroitin sulphate and glucosamine for primary prevention of colorectal cancer. Results from the MCC-Spain study. | |
Postmenopausal Hormone Therapy and Colorectal Cancer Risk by Molecularly Defined Subtypes and Tumor Location | |
Prácticas de cribado de cáncer y estilos de vida asociados en la población de controles del estudio español multi-caso control (MCC-Spain) | |
Predicting pulmonary embolism in postoperative patients with deep venous thrombosis of lower limbs | |
Predicting the change in breast cancer deaths in Spain by 2019: a Bayesian approach | |
Prescription drugs associated with false-positive results when using faecal immunochemical tests for colorectal cancer screening | |
Primary cardiac osteosarcoma | |
The role of dietary patterns in colorectal cancer: a 2019 update | |
The role of the microenvironment in cancer progression and metastasis: an immunogenomics approach | |
The RS4939827 polymorphism in the SMAD7 GENE and its association with Mediterranean diet in colorectal carcinogenesis | |
Solemne investidura com a doctor honoris causa del senyor Francesc Xavier Bosch i José | |
[Time trend of breast cancer incidence in Catalonia]. | |
Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973-1995 | |
Tools for protein-protein interaction network analysis in cancer research. | |
TP53, a gene for colorectal cancer predisposition in the absence of Li-Fraumeni-associated phenotypes | |
Transcriptional Regulator CNOT3 Defines an Aggressive Colorectal Cancer Subtype | |
Transcriptome-wide <i>In Vitro</i> Effects of Aspirin on Patient-derived Normal Colon Organoids | |
Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study | |
Trends in smoking-related cancer incidence in Tarragona, Spain, 1980-96. | |
Tumor Expression of Cyclin-Dependent Kinase 5 (Cdk5) Is a Prognostic Biomarker and Predicts Outcome of Oxaliplatin-Treated Metastatic Colorectal Cancer Patients | |
Tumor Markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in Patients with Non-Small Cell Lung Cancer as an Aid in Histological Diagnosis and Prognosis | |
Tumor Thymidylate Synthase 1494del6 Genotype As a Prognostic Factor in Colorectal Cancer Patients Receiving Fluorouracil-Based Adjuvant Treatment | |
Tumour selection advantage of non-dominant negative P53 mutations in homozygotic MDM2-SNP309 colorectal cancer cells | |
Type 2 Diabetes, Antidiabetic Medications, and Colorectal Cancer Risk: Two Case-Control Studies from Italy and Spain. | |
Type 2 diabetes-related variants influence the risk of developing multiple myeloma: results from the IMMEnSE consortium | |
UGT1A and TYMS genetic variants predict toxicity and response of colorectal cancer patients treated with first-line irinotecan and fluorouracil combination therapy | |
Underexpression of transcriptional regulators is common in metastatic breast cancer cells overexpressing Bcl-xL. | |
Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs | |
Use of non-steroidal anti-inflammatory drugs and risk of breast cancer: The Spanish Multi-Case-control (MCC) study | |
Use of text-message reminders to improve participation in a population-based breast cancer screening program. | |
Use of urinary trichloroacetic acid as an exposure biomarker of disinfection by-products in cancer studies | |
Uso de chips de ADN (microarrays) en medicina: fundamentos técnicos y procedimientos básicos para el análisis estadístico de resultados | |
Uterine factors and risk of pregnancy in IUD users: a nested case-control study | |
Validating a breast cancer score in Spanish women. The MCC-Spain study. | |
Validation of RNA arbitrarily primed PCR probes hybridized to glass cDNA microarrays: application to the analysis of limited samples. | |
Variability in prescription drug expenditures explained by adjusted clinical groups (ACG) case-mix: a cross-sectional study of patient electronic records in primary care | |
Variants genètiques de baixa penetrància en la predisposició germinal al càncer colorectal i la síndrome de poliposi serrada | |
Ventricular arrhythmias in aortic valve disease: a further marker of impaired left ventricular function | |
WAERS: an application for Web-assisted estimation of relative survival | |
[WebSurvCa: web-based estimation of death and survival probabilities in a cohort]. | |
WHICH SALT OF ERYTHROMYCIN IS MOST HEPATOTOXIC? | |
শুদ্ধিপত্র |